8-K

CRH PUBLIC LTD CO 8-K Report (Apr 1, 2014)

Filed April 1, 2014For Securities:CRH

Summary

This 8-K filing from CRH Public Ltd Co, filed on April 1, 2014, primarily concerns notifications of transactions by Persons Discharging Managerial Responsibility (PDMRs) and their associated persons. The key events are the grant of options under a Savings-related Share Option Scheme to several individuals, including Maeve Carton (Finance Director), Neil Colgan, and Jack Golden. These filings provide transparency into executive compensation and potential future shareholdings, which can be an indicator of management's confidence in the company's future performance. Investors should note that these are not transactions involving the disposal or acquisition of existing shares, but rather the granting of options to acquire shares at a specified price in the future. The exercise prices and periods are detailed, offering insight into the potential future dilution or equity participation of these key personnel. The aggregate holdings and options granted are relatively small in proportion to the total issued shares, indicating a measured approach to equity-based compensation.

Key Highlights

  • 1Notification of options granted under CRH's Savings-related Share Option Scheme to key personnel, including Finance Director Maeve Carton, Neil Colgan, and Jack Golden.
  • 2The grants occurred on March 27, 2014, and were formally notified on March 28, 2014.
  • 3Options were granted for Ordinary Shares of €0.32 each, with an exercise price of €17.67 per share.
  • 4Exercise periods vary by individual: Maeve Carton's options are exercisable between August 1, 2019, and January 31, 2020. Neil Colgan's and Jack Golden's options are exercisable between August 1, 2017, and January 31, 2018.
  • 5The filing details the total holdings of these individuals post-notification, including previously held shares and the new options.
  • 6The aggregate percentage of issued shares held by these individuals, including options, remains a small fraction of the total outstanding shares.
  • 7The filing was made under Irish Stock Exchange Listing Rule 6.10 and Central Bank of Ireland Market Abuse Rules, ensuring regulatory compliance.

Frequently Asked Questions

The primary purpose of this 8-K filing is to publicly disclose transactions related to securities held by Persons Discharging Managerial Responsibility (PDMRs) and individuals closely associated with them. Specifically, it reports the grant of options under CRH's Savings-related Share Option Scheme to key executives.

No, these are not direct sales or purchases of existing CRH shares. The filing reports the 'grant' of options, which gives the individuals the right, but not the obligation, to purchase CRH shares at a predetermined price (€17.67) within a specified future timeframe. This is a form of incentive compensation.

The exercise price of €17.67 represents the price at which the executive can buy the shares once the option becomes exercisable. The exercise period defines the window during which they can exercise this right. These details are important as they indicate potential future dilution and the executive's potential gain, which is dependent on the share price exceeding the exercise price during the exercise period.

Based on the information provided, the total number of shares covered by these options and the holdings of the individuals concerned represent a very small percentage of CRH's total issued shares. Therefore, these specific grants are unlikely to cause significant dilution or substantially alter the company's share structure.